CLINICAL EVIDENCE
Efficacy and safety of Sitagliptin, Metformin and Glimepiride FDC tablets in Indian type 2 diabetes: A subgroup analysis of patients aged <50 years
CLINICAL EVIDENCE
Efficacy and safety of Sitagliptin, Metformin and Glimepiride FDC in Indian patients with T2DM: A subgroup analysis of phase 3 study based on BMI
CLINICAL EVIDENCE
Efficacy and safety of Sitagliptin, Metformin and Glimepiride in type 2 diabetes: A phase 3, double-blind, active-controlled study
CLINICAL EVIDENCE
Effect of FDC of Sitagliptin, Glimepiride and Metformin IR on post-prandial blood glucose in patients with T2DM: A post-hoc analysis of phase 3 study
CLINICAL EVIDENCE
Efficacy and safety of two strengths of Sitagliptin, Metformin and Glimepiride in type 2 diabetes mellitus: A subgroup analysis of phase 3 study in India
CLINICAL EVIDENCE
Efficacy and safety of Sitagliptin, Glimepiride, and Metformin IR in Indian patients with T2DM: A phase 3 study subgroup analysis based on HbA1c
CLINICAL EVIDENCE
Effect of Sitagliptin, Metformin, and Glimepiride on fasting blood glucose in Indian Patients with T2DM: A post-hoc analysis of phase 3 study